cheaptrix/billsum-US_congress_and_house huggingface dataset:
Triple A Study Act

To direct the Government Accountability Office to evaluate appropriate coverage of assistive technologies provided to patients who experience amputation or live with limb difference. 1. Short title This Act may be cited as the Access to Assistive Technology and Devices for Americans Study Act Triple A Study Act 2. Appropriate coverage of assistive technologies (a) In general Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall evaluate, and submit to Congress a report on such evaluation, the appropriate coverage, through insurance or otherwise, of assistive technologies provided to patients who experience amputation or live with limb difference, particularly prosthetic devices and custom orthoses, including— (1) timely access to care, including educating patients regarding options for assistive technologies; (2) assessments and guidelines for assistive device determinations; (3) matching specific assistive devices with the needs of the individual beneficiary, such as women; (4) the affordability of assistive devices; (5) the provision of rehabilitation services to support acclimation to assistive devices; and (6) appropriate timelines for assessments for surgery and assessments of assistive devices. (b) Comparison of certain data As part of the evaluation conducted under subsection (a), the Comptroller General shall compare data on practices and outcomes derived from the Medicare program under title XVIII of the Social Security Act ( 42 U.S.C. 1395 (1) the percentage of patients who get access to assistive devices; (2) performance measures that monitor the timeliness of processing prosthetic prescriptions; (3) coverage denials and overturn rates; (4) coding for physician or physical therapy assessments, including whether a prosthetist was engaged in the assessment; (5) the rate of patients returning to work in general, and after receiving a prosthetic device comparable to other assistive technologies; (6) reductions in long-term assistive technology services and supports; (7) with respect to those using assistive technologies, policies to reduce falls and secondary complications, such as diabetes, heart disease, vascular disease, and others; and (8) the amount expended by individual entities on prosthetics relative to total amount expended by such entities.

Summary: Access to Assistive Technology and Devices for Americans Study Act or the Triple A Study Act This bill directs the Government Accountability Office (GAO) to study issues related to health insurance and other coverage for assistive technologies, such as prosthetic devices and custom orthoses, for those who experience amputations or live with a limb difference. In conducting this study, the GAO must include comparisons of claims and other data from Medicare, the Department of Veterans Affairs, and commercial health insurers.
Protecting America From Spies Act

To amend section 212 of the Immigration and Nationality Act to ensure that efforts to engage in espionage or technology transfer are considered in visa issuance, and for other purposes. 1. Short title This Act may be cited as the Protecting America From Spies Act 2. Expanding inadmissibility on security and related grounds (a) In general Section 212(a)(3)(A) of the Immigration and Nationality Act ( 8 U.S.C. 1182(a)(3)(A) (A) In general Any alien is inadmissible if a consular officer or the Secretary of Homeland Security knows, or has reasonable ground to believe, that the alien— (i) engages, has engaged, or will engage in any activity— (I) in violation of any law of the United States relating to espionage or sabotage; or (II) that would violate any law of the United States relating to espionage or sabotage if the activity occurred in the United States; (ii) engages, has engaged, or will engage in any activity in violation or evasion of any law prohibiting the export from the United States of goods, technology, or sensitive information; (iii) seeks to enter the United States to engage solely, principally, or incidentally in any other unlawful activity; (iv) seeks to enter the United States to engage solely, principally, or incidentally in any activity a purpose of which is the opposition to, or the control or overthrow of, the Government of the United States by force, violence, or other unlawful means; or (v) is the spouse or child of an alien who is inadmissible under this subparagraph, if the activity causing the alien to be found inadmissible occurred within the last 5 years. . (b) Waiver authority Section 212(d)(3)(A) of the Immigration and Nationality Act ( 8 U.S.C. 1182(d)(3)(A) (3)(A)(i)(I), (3)(A)(ii), (3)(A)(iii), (3)(A)(iii), (3)(A)(iv),

Summary: Protecting America From Spies Act This bill expands the grounds for barring aliens who have engaged in acts relating to espionage or sabotage from entering the United States. Specifically, any alien shall be inadmissible if the alien has engaged in or will engage in an act that (1) violates a U.S. law relating to espionage or sabotage; (2) would violate any U.S. law relating to espionage or sabotage if it occurred in the United States; or (3) violates any U.S. law prohibiting the export of goods, technology, or sensitive information. Currently, an alien shall be inadmissible if the alien seeks to enter the United States to engage in such an action. Furthermore, the bill expands these grounds of inadmissibility and other security-related grounds to cover the spouse or child of the barred alien if the act occurred in the last five years. The bill also modifies the authority of the Department of Justice to waive certain security-related grounds of inadmissibility for an alien applying for a nonimmigrant visa.
Rural Health Care Access Review Act of 2020

To provide for the conduct of a GAO study and report on rural health access during the COVID–19 pandemic. 1. Short title This Act may be cited as the Rural Health Care Access Review Act of 2020 2. GAO study and report on rural health access during the COVID–19 pandemic (a) Study The Comptroller General of the United States shall conduct a study on access to health care in rural areas during the public health emergency described in section 1135(g)(1)(B) of the Social Security Act ( 42 U.S.C. 1320b–5(g)(1)(B) (1) To the extent data are available, an analysis of access, quality, patient and provider experience, and spending and utilization of telehealth services furnished during such public health emergency. Such evaluation shall be broken out by each of the following: (A) Individuals enrolled in the Medicare and Medicaid programs. (B) The provider type and medical specialty of the practitioner furnishing the telehealth service. (C) The modality under which such telehealth services were furnished— (i) using audio-only technology; and (ii) using audio-visual technology. (2) To the extent data are available, an analysis of how these flexibilities influenced private payer policies on telehealth. (3) To the extent data are available, an analysis of disparities in access to, and quality of, telehealth services during such public health emergency. (4) To the extent data are available, an analysis of barriers to accessing and providing telehealth services covered by the Medicare or Medicaid programs, including those related to broadband infrastructure. (5) An analysis of what is known about the privacy impacts of the waiver of Federal privacy regulations during such public health emergency. (b) Report Not later than 24 months after the date of enactment of this Act, the Comptroller General shall submit a report to the Committee on Finance and the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Ways and Means and the Committee on Energy and Commerce of the House of Representatives containing the results of the study conducted under subsection (a). (c) Definition of rural area In this section, the term rural area

Summary: Rural Health Care Access Review Act of 2020 This bill requires the Government Accountability Office to conduct a study on access to health care in rural areas during the COVID-19 (i.e., coronavirus disease 2019) emergency. Specifically, this study must evaluate the use of telehealth and the impact of enforcement discretion in the application of federal privacy standards for the use and disclosure of personal health information by health care providers, health plans, health clearinghouses, and their businesses associates.
TRUST CDC Act

To require States and hospitals to report COVID–19 health data directly to the Centers for Disease Control and Prevention. 1. Short title This Act may be cited as the Transparent Reporting and Use of Statistics in the Transmission of Coronavirus Data Collection TRUST CDC Act 2. Sharing of COVID–19 health data (a) In general Notwithstanding the updates to the guidance of the White House Coronavirus Task Force entitled, COVID–19 Guidance for Hospital Reporting and FAQs For Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting (b) Public posting of data; updates The Director of the Centers for Disease Control and Prevention shall— (1) not later than 7 days after the date of enactment of this Act, reinstate the website of such agency containing COVID–19 data, including the number of cases, deaths, and diagnostic and serologic tests per State; and (2) update such data on such website daily thereafter.

Summary: Transparent Reporting and Use of Statistics in the Transmission of Coronavirus Data Collection or the TRUST CDC Act This bill nullifies specified guidance issued by the White House Coronavirus Task Force on July 10, 2020, concerning the reporting of state and hospital COVID-19 (i.e., coronavirus disease 2019) data. Specifically, states and hospitals must revert to reporting this data directly to the Centers for Disease Control and Prevention (CDC). Under the task force guidance, they report it to the Department of Health and Human Services. In addition, the CDC must reinstate, and update daily, a particular website that reported certain COVID-19 data, including the number of cases and deaths in each state.
A bill to require the Secretary of Agriculture to make recourse loans available to commercial processors of dairy products during the COVID-19 pandemic, and for other purposes.

To require the Secretary of Agriculture to make recourse loans available to commercial processors of dairy products during the COVID–19 pandemic, and for other purposes. 1. Recourse loan program for commercial processors of dairy products (a) Definitions In this section: (1) COVID– 19 The term COVID–19 (2) Eligible dairy product The term eligible dairy product (3) Qualified applicant The term qualified applicant (4) Secretary The term Secretary (b) Availability of loans The Secretary shall make recourse loans available to qualified applicants during the COVID–19 pandemic. (c) Amount of loans (1) In general A recourse loan made under this section shall be provided to qualified applicants up to the value of the eligible dairy product inventory of the applicant, as determined by the Secretary and consistent with subsection (d). (2) Valuation For purposes of making recourse loans under this section, the Secretary shall conduct eligible dairy product valuations to provide, to the maximum extent practicable, funds to continue the operations of qualified applicants. (d) Inventory used as collateral Eligible dairy product inventory used as collateral for the recourse loan program under this section shall be pledged on a rotating basis to prevent spoilage of perishable products. (e) Term of loans A recourse loan under this section may be made for a period as determined by the Secretary, except that no recourse loan under this section may end after the date that is 24 months after the date of enactment of this section. (f) Funding Out of any amounts in the Treasury not otherwise appropriated, there is appropriated to carry out this section $500,000,000. (g) Emergency designation (1) In general The amounts provided by this Act are designated as an emergency requirement pursuant to section 4(g) of the Statutory Pay-As-You-Go Act of 2010 ( 2 U.S.C. 933(g) (2) Designation in Senate In the Senate, this Act is designated as an emergency requirement pursuant to section 4112(a) of H. Con. Res. 71 (115th Congress), the concurrent resolution on the budget for fiscal year 2018.

Summary: This bill requires the Department of Agriculture to make recourse loans available to commercial processors, packagers, or merchandisers of dairy products during the COVID-19 (i.e., coronavirus disease 2019) pandemic. The bill also provides funding for the loans and specifies that loans shall be provided to applicants for up to the value of the dairy product inventory of such applicants. Dairy product inventory used as collateral for the recourse loan program shall be pledged on a rotating basis to prevent spoilage of perishable products.
Katherine's Lung Cancer Early Detection and Survival Act of 2020

To amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers offering group or individual health insurance coverage to provide benefits for lung cancer screenings for certain individuals without the imposition of cost sharing. 1. Short title This Act may be cited as the Katherine’s Lung Cancer Early Detection and Survival Act of 2020 2. Findings Congress finds the following: (1) Among cancers, lung cancer is the number 1 killer. (2) Lung cancer causes more deaths than prostate cancer, breast cancer, and colorectal cancer combined. (3) The reason for the extremely low 5-year survival rate in lung cancer patients is the difficulty to find it at early stages (as patients have no symptoms at early stages). (4) For all stages of lung cancer, the overall 5-year survival rate is 19 percent, while such rate is 98 percent for prostate cancer and 90 percent for breast cancer (all stages). (5) Early detection of lung cancer through screening could dramatically increase survival rates for patients. (6) Current law mandates free screening for breast cancer, prostate cancer, and colorectal cancer at much earlier ages than for lung cancer, regardless of preexisting conditions of the individual to be screened. (7) Free screening starts at age 40 for breast cancer but for lung cancer does not start until age 55, and then and only for individuals with a history of smoking 30 or more packs of cigarettes per year. (8) This Act would save lives and money through early detection of lung cancer by starting free screening at age 40. 3. Requiring coverage of lung cancer screenings for certain individuals without cost sharing (a) In general Section 2713(a) of the Public Health Service Act ( 42 U.S.C. 300gg–13(a) (1) in paragraph (2), by striking and (2) in paragraph (3), by striking the period at the end and inserting a semicolon; (3) in paragraph (4), by striking the period at the end and inserting ; and (4) by redesignating paragraph (5) as paragraph (6); and (5) by inserting after paragraph (4) the following new paragraph: (5) with respect to individuals 40 years of age or older, lung cancer screenings, regardless of the smoking history (if any) of such an individual. . (b) Effective date The amendments made by subsection (a) shall apply with respect to plan years beginning on or after January 1, 2021.

Summary: Katherine's Lung Cancer Early Detection and Survival Act of 2020 This bill requires private health insurance plans to cover, without cost sharing, screenings for the detection of lung cancer for individuals 40 years of age and older without regard to such individual's smoking history.
Blue Ridge National Heritage Area Reauthorization Act of 2020

To reauthorize the Blue Ridge National Heritage Area, and for other purposes. 1. Short title This Act may be cited as the Blue Ridge National Heritage Area Reauthorization Act of 2020 2. Reauthorization of the Blue Ridge National Heritage Area The Blue Ridge National Heritage Area Act of 2003 ( 54 U.S.C. 320101 Public Law 108–108 (1) in subsection (i)— (A) by striking paragraph (1) and inserting the following: (1) In general There is authorized to be appropriated to carry out this section $1,000,000 for each fiscal year. ; and (B) in paragraph (2), by striking subsection (a) paragraph (1) (2) in subsection (j), by striking 2021 2036

Summary: Blue Ridge National Heritage Area Reauthorization Act of 2020 This bill extends through FY2036 the authority of the Department of the Interior to provide assistance for the Blue Ridge National Heritage Area in North Carolina and removes the limitation on the total amount that may be appropriated for the heritage area.
A bill to amend the Tariff Act of 1930 to require online retailers to disclose whether articles sold by such retailers originate in the People's Republic of China, and for other purposes.

To amend the Tariff Act of 1930 to require online retailers to disclose whether articles sold by such retailers originate in the People's Republic of China, and for other purposes. 1. Disclosure by online retailers of whether articles originate in the People's Republic of China (a) In general Section 304 of the Tariff Act of 1930 ( 19 U.S.C. 1304 (m) Marking of articles from the People's Republic of China sold by online retailers (1) In general Any person that sells, through an online marketplace or e-commerce platform, articles of foreign origin imported into the United States, shall state as legibly as possible, in a conspicuous place on the webpage for each such article, if any of the following is the People's Republic of China: (A) The country of origin of the article. (B) The country of origin of any major component of the article. (C) The country in which the article was manufactured. (D) The country in which the article was assembled. (2) Application of certain provisions The following provisions of this section shall apply with respect to the statement required by paragraph (1) to the same extent that such provisions apply with respect to the marking of articles under subsection (a): (A) Paragraphs (1) and (2) of subsection (a). (B) Subparagraphs (E), (H), (I) of subsection (a)(3). (C) Subsections (f), (g), (h), (k), and (l). . (b) Regulations The Secretary of the Treasury shall prescribe regulations to carry out subsection (m) of section 304 of the Tariff Act of 1930, as added by subsection (a), which regulations may include exceptions to the requirements of that subsection for small retailers or for second point-of-sale retailers. (c) Applicability The amendment made by subsection (a) shall apply with respect to articles entered, or withdrawn from warehouse for consumption, on or after the date that is 15 days after the date of the enactment of this Act.

Summary: This bill requires an online retailer to disclose whether articles sold through its platform originate in China. Specifically, any online retailer selling articles of foreign commerce imported into the United States shall legibly state and conspicuously disclose on the webpage for each such article if the article or any major component thereof originates in China or if the article was manufactured or assembled in China. The bill also authorizes the Department of the Treasury to determine the acceptable method of disclosure and to authorize the exception of certain articles from disclosure requirements. Further, such disclosure is not required to be made for specified types of products (e.g., coffee and tea, spices, and silk products).
A bill to clarify licensure requirements for contractor medical professionals to perform medical disability examinations for the Department of Veterans Affairs, and for other purposes.

To clarify licensure requirements for contractor medical professionals to perform medical disability examinations for the Department of Veterans Affairs, and for other purposes. 1. Clarification of licensure requirements for contractor medical professionals to perform medical disability examinations for the Department of Veterans Affairs Subsection (c) of section 504 of the Veterans’ Benefits Improvements Act of 1996 ( Public Law 104–275 38 U.S.C. 5101 (c) Licensure of contract health care professionals (1) In general Notwithstanding any law regarding the licensure of health care professionals, a health care professional described in paragraph (2) may conduct an examination pursuant to a contract entered into under subsection (a) at any location in any State, the District of Columbia, or a Commonwealth, territory, or possession of the United States, so long as the examination is within the scope of the authorized duties under such contract. (2) Health care professional described A health care professional described in this paragraph is a physician, physician assistant, nurse practitioner, audiologist, or psychologist, who— (A) has a current unrestricted license to practice the health care profession of the physician, physician assistant, nurse practitioner, audiologist, or psychologist, as the case may be; (B) is not barred from practicing such health care profession in any State, the District of Columbia, or a Commonwealth, territory, or possession of the United States; and (C) is performing authorized duties for the Department of Veterans Affairs pursuant to a contract entered into under subsection (a). .

Summary: This bill authorizes additional health care professionals to perform medical disability examinations as part of the Department of Veterans Affairs (VA) pilot program. Currently, the pilot program authorizes physicians with current and unrestricted licenses to perform medical disability examinations on persons applying for VA benefits. Under the bill, the following contract health care professionals are authorized to perform such examinations if they meet licensure requirements: physicians, physician assistants, nurse practitioners, audiologists, and psychologists.